UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 563

Sortiert nach

C-reactive protein (CRP) as a biomarker of pulmonary exacerbation presentation and treatment response

Journal of cystic fibrosis, 2022-07, Vol.21 (4), p.588-593

2022

Volltextzugriff (PDF)

Association of site of treatment with clinical outcomes following intravenous antimicrobial treatment of a pulmonary exacerbation

Journal of cystic fibrosis, 2022-07, Vol.21 (4), p.574-580

2022

Volltextzugriff (PDF)

Building global development strategies for cf therapeutics during a transitional cftr modulator era

Journal of cystic fibrosis, 2020-09, Vol.19 (5), p.677-687

2020

Volltextzugriff (PDF)

Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis

Thorax, 2004-11, Vol.59 (11), p.955-959

2004

Volltextzugriff (PDF)

Changes in symptom scores as a potential clinical endpoint for studies of cystic fibrosis pulmonary exacerbation treatment

Journal of cystic fibrosis, 2021-01, Vol.20 (1), p.36-38

2021

Volltextzugriff (PDF)

Patient-reported respiratory symptoms in cystic fibrosis

Journal of cystic fibrosis, 2009-07, Vol.8 (4), p.245-252

2009

Volltextzugriff (PDF)

Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection

Thorax, 2013-09, Vol.68 (9), p.818-825

2013

Volltextzugriff (PDF)

Exacerbations in cystic fibrosis · 1 : Epidemiology and pathogenesis

Thorax, 2007-04, Vol.62 (4), p.360-367

2007

Volltextzugriff (PDF)

Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: The early intervention in cystic fibrosis exacerbation (eICE) trial

Contemporary clinical trials, 2013-11, Vol.36 (2), p.460-469

2013

Volltextzugriff (PDF)

Long-term treatment with oral N-acetylcysteine: Affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial

Journal of cystic fibrosis, 2015-03, Vol.14 (2), p.219-227

2015

Volltextzugriff (PDF)

Antipseudomonal treatment decisions during CF exacerbation management

Journal of cystic fibrosis, 2022-09, Vol.21 (5), p.753-758

2022

Volltextzugriff (PDF)

Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosis

Journal of cystic fibrosis, 2017-09, Vol.16 (5), p.607-615

2017

Volltextzugriff (PDF)

Duration of Antibiotic Therapy in Non-cystic Fibrosis Bronchiectasis

Current pulmonology reports, 2019-12, Vol.8 (4), p.160-165

2019

Volltextzugriff (PDF)

The association of month of birth with atopy in adult patients with asthma and rhinitis in Anatolia, Turkey

Allergologia et immunopathologia, 2012-11, Vol.40 (6), p.346-351

2012

Volltextzugriff (PDF)

The cystic fibrosis therapeutics development network (CF TDN): a paradigm of a clinical trials network for genetic and orphan diseases

Advanced drug delivery reviews, 2002-12, Vol.54 (11), p.1505-1528

2002

Volltextzugriff (PDF)

A validated method to measure benzo[a]pyrene concentrations in tobacco by high-performance liquid chromatography-fluorescence detection

Analytical methods, 2015-01, Vol.7 (4), p.159-1599

2015

Volltextzugriff (PDF)

Experience using centralized spirometry in the phase 2 randomized, placebo-controlled, double-blind trial of denufosol in patients with mild to moderate cystic fibrosis

Journal of cystic fibrosis, 2008-03, Vol.7 (2), p.147-153

2008

Volltextzugriff (PDF)

Children and young adults with CF in the USA have better lung function compared with the UK

Thorax, 2015-03, Vol.70 (3), p.229-236

2015

Volltextzugriff (PDF)

Characteristics and Outcomes of Children With Cystic Fibrosis Hospitalized With Cirrhosis in the United States

The American journal of gastroenterology, 2021-08, Vol.116 (8), p.1734-1737

2021

Volltextzugriff (PDF)

Treatment of lung infection in patients with cystic fibrosis: Current and future strategies

Journal of cystic fibrosis, 2012-12, Vol.11 (6), p.461-479

2012

Volltextzugriff (PDF)

A story of success: continuous quality improvement in cystic fibrosis care in the USA

Thorax, 2011-12, Vol.66 (12), p.1106-1108

2011

Volltextzugriff (PDF)

Cystic Fibrosis Pulmonary Guidelines: Treatment of Pulmonary Exacerbations

American journal of respiratory and critical care medicine, 2009-11, Vol.180 (9), p.802-808

2009

Volltextzugriff (PDF)

Clinical Trial Participants Compared with Nonparticipants in Cystic Fibrosis

American journal of respiratory and critical care medicine, 2006-01, Vol.173 (1), p.98-104

2006

Volltextzugriff (PDF)

B102 STRATEGIES TO IMPROVE CARE QUALITY IN PULMONARY AND CRITICAL ILLNESS: Low Lung Function And Lung Transplant Referral For Cystic Fibrosis

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

1 – 25 von 563

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(516)
Mit Volltextzugriff
(505)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

C-reactive protein (CRP) as a biomarker of pulmonary exacerbation presentation and treatment response

Association of site of treatment with clinical outcomes following intravenous antimicrobial treatment of a pulmonary exacerbation

Building global development strategies for cf therapeutics during a transitional cftr modulator era

Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis

Changes in symptom scores as a potential clinical endpoint for studies of cystic fibrosis pulmonary exacerbation treatment

Patient-reported respiratory symptoms in cystic fibrosis

Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection

Exacerbations in cystic fibrosis · 1 : Epidemiology and pathogenesis

Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: The early intervention in cystic fibrosis exacerbation (eICE) trial

Long-term treatment with oral N-acetylcysteine: Affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial

Antipseudomonal treatment decisions during CF exacerbation management

Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosis

Duration of Antibiotic Therapy in Non-cystic Fibrosis Bronchiectasis

The association of month of birth with atopy in adult patients with asthma and rhinitis in Anatolia, Turkey

The cystic fibrosis therapeutics development network (CF TDN): a paradigm of a clinical trials network for genetic and orphan diseases

A validated method to measure benzo[a]pyrene concentrations in tobacco by high-performance liquid chromatography-fluorescence detection

Experience using centralized spirometry in the phase 2 randomized, placebo-controlled, double-blind trial of denufosol in patients with mild to moderate cystic fibrosis

Children and young adults with CF in the USA have better lung function compared with the UK

Characteristics and Outcomes of Children With Cystic Fibrosis Hospitalized With Cirrhosis in the United States

Treatment of lung infection in patients with cystic fibrosis: Current and future strategies

A story of success: continuous quality improvement in cystic fibrosis care in the USA

Cystic Fibrosis Pulmonary Guidelines: Treatment of Pulmonary Exacerbations

Clinical Trial Participants Compared with Nonparticipants in Cystic Fibrosis

Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study

B102 STRATEGIES TO IMPROVE CARE QUALITY IN PULMONARY AND CRITICAL ILLNESS: Low Lung Function And Lung Transplant Referral For Cystic Fibrosis

Suchergebnisse filtern